- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/18 - Bridged systems
Patent holdings for IPC class C07D 513/18
Total number of patents in this class: 137
10-year publication summary
|
8
|
4
|
7
|
6
|
8
|
9
|
7
|
11
|
9
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19961 |
11 |
| City of Hope | 994 |
8 |
| Gilead Sciences, Inc. | 2032 |
8 |
| Colorado State University Research Foundation | 706 |
7 |
| Mutabilis | 27 |
6 |
| Daiichi Sankyo Company, Limited | 1877 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
5 |
| University of Notre Dame du Lac | 566 |
5 |
| Pfizer Inc. | 3371 |
3 |
| University of Florida Research Foundation, Inc. | 4035 |
3 |
| Cetya Therapeutics, Inc. | 3 |
3 |
| Elanco Animal Health Ireland Limited | 3 |
3 |
| Oncodesign S.A. | 15 |
3 |
| Sanofi | 4072 |
3 |
| Novartis AG | 10744 |
2 |
| Bristol-myers Squibb Company | 4880 |
2 |
| Glaxosmithkline LLC | 537 |
2 |
| Janssen Pharmaceutica N.V. | 3394 |
2 |
| Wisconsin Alumni Research Foundation | 3894 |
2 |
| Takeda Pharmaceutical Company Limited | 2708 |
2 |
| Other owners | 52 |